Reduction of dimesna to mesna by the isolated perfused rat liver

Cancer Research

Volumn 58, Issue 19, 1998, Pages 4358-4362

  Goren, Marshall P ^a   Hsu, Li C ^a   Li, Jackie T ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESNA;

ANIMAL EXPERIMENT; ARTICLE; DRUG DISPOSITION; DRUG OXIDATION; FEMALE; HEMORRHAGIC CYSTITIS; LIVER METABOLISM; LIVER PERFUSION; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

ANIMALS; BIOTRANSFORMATION; BUTHIONINE SULFOXIMINE; FEMALE; GLUTATHIONE; KINETICS; LIVER; MESNA; OXIDATION-REDUCTION; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032190058     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Brock, N. Oxazaphosphorine cytostatics: past-present-future - Seventh Cain Memorial Award lecture. Cancer Res., 49: 1-7, 1989.
2. Brock, N., Pohl, J., Stekar, J., and Scheef, W. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention-III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna). Eur. J. Cancer Clin. Oncol., 18: 1377-1387, 1982.
3. Brock, N., and Pohl, J. The development of mesna for regional detoxification. Cancer Treat. Rev., 10 (Suppl. A): 33-43, 1983.
4. Ormstad, K., Orrenius, S., Lastborn, T., Uehara, N., Pohl, J., Stekar, J., and Brock, N. Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat. Cancer Res., 43: 333-338, 1983.
5. Ormstad, K., and Ohno, Y. N-acetylcysteine and sodium 2-mercaptoethane sulfonate as sources of urinary thiol groups in the rat. Cancer Res., 44: 3797-3800, 1984.
6. 14C]-mesna in the rat. Arzneim-forsch., 36: 487-489, 1986.
7. Shaw, I. C., and Graham, M. I. Mesna - a short review. Cancer Treat. Rev., 14: 67-86, 1987.
8. Brock, N., Stekar, J., Pohl, J., Niemeyer, U., and Scheffler, G. Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide. Arzneim-forsch., 29: 659-661, 1979.
9. Cox, P. J. Cyclophosphamide cystitis - identification of acrolein as the causative agent. Biochem. Pharmacol., 28: 2045-2049, 1979.
10. Goren, M. P., Houle, J. M., Bush, D. A., Li, J. T., Newman, C. E., and Brade, W. P. Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects. Clin. Cancer Res., in press, 1998.
11. Goren, M. P., McKenna, L. M., and Goodman, T. L. Combined intravenous and oral mesna in outpatients treated with ifosfamide. Cancer Chemother. Pharmacol., 40: 371-375, 1997.
12. Goren, M. P., Anthony, L. B., Hande, K. R., Johnson, D. H., Brade, W. P., Bush, D. A., Frazier, M. W., and Li, J. T. Pharmacokinetics of an IV-oral versus IV mesna administration regimen in lung cancer patients receiving ifosfamide. J. Clin. Oncol., 16: 616-621, 1998.
13. James, C. A., Mant, T. G., and Rogers, H. J. Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects. Br. J. Clin. Pharmacol., 23: 561-568, 1987.
14. Lauterburg, B. H., Nguyen, T., Hartmann, B., Junker, E,. Kupfer, A., and Cerny, T. Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/ mesna therapy. Cancer Chemother. Pharmacol., 35: 132-136, 1994.
15. Deneke, S. M., and Fanburg, B. L. Regulation of cellular glutathione. Am. J. Physiol., 257: L163-L173, 1989.
16. Mulder, G. J., and Ouwerkerk-Mahadevan, S. Modulation of glutathione conjugation in vivo: how to decrease glutathione conjugation in vivo or in intact cellular systems in vitro. Chem.-Biol. Interact., 105: 17-34, 1997.
17. Meijer, D. K., Keulemans, K., and Mulder, G. J. Isolated perfused rat liver technique. Methods Enzymol., 77: 81-94, 1981.
18. Kari, F. W., Kauffman, F. C., and Thurman, R. G. Effect of bile salts on rates of formation, accumulation, and export of mutagenic metabolites from benzo(a)pyrene produced by the perfused rat liver. Cancer Res., 45: 1621-1627, 1985.
19. Brouwer, K. L. R., and Thurman, R. G. Isolated perfused liver. In: R. T. Borchardt (ed.), Models for Assessing Drug Absorption and Metabolism, pp. 161-192. New York: Plenum Press, 1996.
20. Griffith, O. W., and Meister, A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J. Biol. Chem., 254: 7558-7560, 1979.
21. Torres, A. M., Rodriguez, J. V., Ochoa, J. E., and Elias, M. M. Rat kidney function related to tissue glutathione levels. Biochem. Pharmacol., 35: 3355-3358, 1986.
22. Crawhall, J. C., and Kalant, D. Measurement of biological disulfides by postcolumn sulfitolysis following separation by HPLC. Anal. Biochem., 172: 479-483, 1988.
23. Lind, M. J., McGown, A. T., Hadfield, J. A., Thatcher, N., Crowther, D., and Fox, B. W. The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo. Biochem. Pharmacol., 38: 1835-1840, 1989.
24. Brock, N., Pohl, J., and Stekar, J. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention-I. Experimental studies on the urotoxicity of alkylating compounds. Fur. J. Cancer. 17: 595-607, 1981.
25. Kern, A., Bader, A., Pichlmayr, R., and Sewing, K. F. Drug metabolism in hepatocyte sandwich cultures of rats and humans. Biochem. Pharmacol., 54: 761-772, 1997.
26. Ouwerkerk-Mahadevan, S., van, B. J., Dreef-Tromp, M. C., Ploemen, J. H., Meyer, D. J., and Mulder, G. J. Glutathione analogues as novel inhibitors of rat and human glutathione S-transferase isoenzymes, as well as of glutathione conjugation in isolated rat hepatocytes and in the rat in vivo. Biochem. J., 308: 283-290, 1995.
27. Lin, J. H. Species similarities and differences in pharmacokinetics. Drug Metab. Dispos., 23: 1008-1021, 1995.
28. Boyd, E. Normal variability in weight of the adult human liver and spleen. Arch. Pathol., 16: 350-372, 1933.
29. Shaw, I. C., and Weeks, M. S. Interaction between mesna and selected transition metals in vitro and in vivo. Arzneim-forsch., 36: 997-1000, 1986.
30. Guyton, A. C., and Hall, J. E. The liver as an organ. In: Textbook of Medical Physiology, pp. 883-888. Philadelphia: W. B. Saunders Company, 1996.
31. Pettersen, J. C., Morrissey, R. L., Saunders, D. R., Pavkov, K. L., Luempert, L. G., Turnier, J. C., Matheson, D. W., and Schwartz, D. R. A 2-year comparison study of Crl:CD BR and Hsd:Sprague-Dawley SD rats. Fundam. Appl. Toxicol., 33: 196-211, 1996.